• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Thera (NQ: VKTX )

    73.56 +1.02 (+1.40%)
    Streaming Delayed Price Updated: 10:05 AM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Viking Thera

    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 14
    ...
    18 19 Next >
    Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
    The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break. 
    Via Investor's Business Daily
    7 Stocks That Will Drive the Weight Loss Drugs Market
    The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. 
    Via MarketBeat
    5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
    This high-flying biotech stock has captured investors' attention for all the right reasons. 
    Via The Motley Fool
    3 Biotech Stocks to Buy on the Dip: March 2024
    Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
    Via InvestorPlace
    Viking Therapeutics: Buy, Sell, or Hold?
    It has a promising candidate and plenty of cash in hand. 
    Via The Motley Fool
    2 Incredible Growth Stocks to Buy Right Now
    These two biotech stocks could be big winners in the years ahead. 
    Via The Motley Fool
    Viking Therapeutics Unusual Options Activity For March 19
    Via Benzinga
    Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
    Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in New York. The S&P 500 saw a modest uptick of 0.3% for the day, with the Dow... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... 
    Via Benzinga
    Warning: This Skyrocketing Stock Has a Hidden Risk
    Don't bet on this pitfall happening, but know that it's a possibility. 
    Via The Motley Fool
    Where Will Viking Therapeutics Be in 5 Years?
    Expectations for the stock are high, and it could well deliver. 
    Via The Motley Fool
    Will Viking Therapeutics Get Acquired?
    Would an acquisition be good news for Viking Therapeutics investors? 
    Via The Motley Fool
    DNUT Stock Soars 29% as McDonald’s Deal Supercharges Krispy Kreme
    Krispy Kreme stock is rising higher on Tuesday with heavy trading of DNUT shares alongside a new collaboration agreement with McDonald’s. 
    Via InvestorPlace
    Why Viking Therapeutics Stock Is Skyrocketing Today
    The high-flying biotech company delivered more good news about a weight loss drug candidate. 
    Via The Motley Fool
    MSTR Stock Alert: MicroStrategy Releases New AI Bot
    MicroStrategy stock is up on Tuesday as investors in MSTR shares react to news of a new AI bot released by the data analytics company. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
    Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results. 
    Via InvestorPlace
    Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
    Explore Viking Therapeutics' Phase 1 MAD trial results for oral VK2735, a promising treatment for metabolic disorders like obesity. Dose-dependent reductions in body weight, encouraging... 
    Via Benzinga
    Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
    People lost more weight than the company expected over a 28-day study. 
    Via Investor's Business Daily
    Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
    All three of these high-flying stocks could have more room to run. 
    Via The Motley Fool
    2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
    Find out why investment banks up and down Wall Street have big expectations for these stocks. 
    Via The Motley Fool
    Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
    Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. 
    Via InvestorPlace
    Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
    Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants. 
    Via The Motley Fool
    Is Viking Therapeutics Stock a Millionaire Maker?
    Viking Therapeutics has become one of the hottest healthcare stocks of 2024. 
    Via The Motley Fool
    Where Will Viking Therapeutics Stock Be in 10 Years?
    Viking's future appears to be very promising, but market dynamics can change. 
    Via The Motley Fool
    With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
    The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs. 
    Via The Motley Fool
    Could Viking Therapeutics Become the Next Eli Lilly?
    Viking shares have skyrocketed on its recent good news. 
    Via The Motley Fool
    Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
    The company might enter the hottest segment in the pharmaceutical sphere before long. 
    Via The Motley Fool
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
    Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. 
    Via The Motley Fool
    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 14
    ...
    18 19 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.